KiraGen Bio
PrivateLast Round
Grant
Dec 31, 2025
Total Funding Raised
$1.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KiraGen Bio is a biotechnology company that develops multiplex gene-edited CAR-T cell therapies designed to overcome the immunosuppressive tumor microenvironment in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KiraGen Bio Comparables
Compare KiraGen Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outpace Bio | 78% | |
| ArsenalBio | 77% | |
| BrainChild Bio, Inc. | 77% |
KiraGen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 31, 2025 | ||||
| Accelerator | Apr 23, 2025 | ||||
| Pre Seed | Apr 1, 2025 |
Key People
Founding team and executive leadership
KiraGen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lexi Ventures | Pre Seed |
| Harvard Innovation Labs | Pre Seed |
| Gaingels | Pre Seed |
| Yuvaan Tiwari Foundation | Pre Seed |
| ZAKA VC | Pre Seed |
| Conscience VC | Pre Seed |
| 2048 Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Secured $50K in grant funding.
- Jul 12, 2025
Featured on The Sheekey Science Show.
Recent news
Latest coverage and updates
- hiresJun 17, 2026
KiraGen Bio hires Devon Shedlock as scientific advisor.
KiraGen Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KiraGen Bio's valuation, stock price, and market status.
Is KiraGen Bio a public or private company?
KiraGen Bio is a private company.
What is the current stock price of KiraGen Bio?
KiraGen Bio is a private company with no public stock price. No recent secondary market data is available.
How much is KiraGen Bio worth (valuation)?
Valuation information for KiraGen Bio is not publicly available.
Can I buy KiraGen Bio stock?
KiraGen Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KiraGen Bio's last funding round?
KiraGen Bio's most recent funding round was Accelerator on April 23, 2025.
Who are the main investors in KiraGen Bio?
Key investors in KiraGen Bio include ZAKA VC, Conscience VC.
Will KiraGen Bio IPO soon?
No public IPO plans have been announced for KiraGen Bio.
How can I track KiraGen Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KiraGen Bio's secondary market activity and sign up for updates.